Arca Biopharma | ABIO - Assets


Arca Biopharma reported $488.62M in Assets for its fiscal quarter ending in December of 2025.





Assets Change Date
Alterity Therapeutics Limited AUD 37.98M 15.78M Dec/2025
Amgen USD 90.59B 445M Dec/2025
Arca Biopharma USD 488.62M 20.63M Dec/2025
Biogen USD 29.44B 232M Dec/2025
Brainstorm Cell Therapeutics USD 1.02M 358K Dec/2025
Bristol-Myers Squibb USD 96.89B 2.21B Sep/2025
Capricor Therapeutics USD 355.95M 229.51M Dec/2025
Cipla INR 401.64B 27.77B Sep/2025
Clal Biotechnology ILS 158.39M 24.3M Dec/2023
Compugen USD 156.57M 58.73M Dec/2025
CSL USD 37.9B 1.5B Dec/2025
Cytokinetics USD 1.42B 12.02M Dec/2025
Daiichi Sankyo JPY 3.82T 252.52B Dec/2025
Gilead Sciences USD 59.02B 490M Dec/2025
GlaxoSmithKline GBP 61.12B 221M Dec/2025
Grifols EUR 23.15B 142.7M Dec/2025
Laboratory Of America USD 18.39B 131.1M Dec/2025
Myriad Genetics USD 706.6M 21.5M Dec/2025
Otsuka Holdings JPY 4.2T 238.02B Dec/2025
Pfizer USD 208.73B 2.64B Sep/2025
United Therapeutics USD 7.88B 528.9M Dec/2025